REFERENCES

Bothara R, Raval R, Kapoor A. Large cell poorly differentiated neuroendocrine carcinoma of

the maxilla: An extremely rare tumor. JSS Case Reports & Reviews 2014;1(7):22-24.
Pathol JC. Neuroendocrine tumours in rare sites: differences in nomenclature and diagnostics.
Journal of clinical pathology. 2016;69(7):563-574
Barnes L, Eveson JW, Reichart P, et al. Neuroendocrine Tumours in:
Pathology and genetics of
head and neck tumours. WHO Classification of Tumours. Lyon
2005:26-30
Nagy AA, Trombitas V, et al. Sinonasal neuroendocrine carcinoma-a case report.romanian
Journal of Rhinology 2014;4(14):117-120
McCollister, Brian D, Hoppr, et al. Sinonasal neoplasma: update on classification, imaging
features and management. Appl Radiol.2015;44(12):7-15
Carrau RL, Meyers AD, et al.
cavity.Otolaryngology and Facial
Plastic Surgery.2015;846-995

Malignant

tumors

of

the

nasal

Krishnamurthy A, Ravi P, et al. Small cell neuroendocrine carcinoma of the

paranasal sinus.
National journal of Maxillofacial Surgery.2013;4(1):111-113.
SmithS.R,SomP,FahmyA.,LawsonW.etal.AClinicopathologicalStudyofSinonasal
Neuroendocrine Carcinoma and Sinonasal Undifferentiated Carcinoma. The
Laryngoscope.,2000Oct;110(10):16171622.
RischinD.,ColemanA.SinonasalMalignanciesofNeuroendocrineOrigin.Hematology
OncologyClinic,2008;22:12971316.
Cohen Z.R., Marmor E., Fuller G.N., Demonte F. Misdiagnosis of olfac tory
neuroblastoma.
NeurosurgFocus.,2002;12:e3.
RosenthalD.I.,BarkerJ.J.,ElNaggarA.K,etal.Sinonasalmalignancieswith
neuroendocrinedifferentiation:patternsoffailureaccordingtohistologicphenotype.
Cancer.,2004;101:25672573.

Perez-Ordonez B. Neuroendocrine tumors. In: Barnes L, Eveson JW, Reichart P, et al.,

eds. World HealthOrganization classification of tumours. Pathology and genetics.
Head and neck tumours. Lyon: IARC Press, 2005;267.

Weinreb I, Perez-Ordoez B. Non-small cell neuroendocrine carcinoma of the sinonasal tract

and nasopharynz. Report of 2 cases and review of the literature. Head Neck
Pathol 2007;1:216.

Tilson MP, Gallia GL, Bishop JA. Among sinonasal tumors, CDX-2 immunoexpression is not
restricted to intestinal-type adenocarcinomas. Head Neck Pathol 2014;8:5965.

Hojo H, Zenda S, Akimoto T, et al. Impact of early radiological response evaluation on

radiotherapeutic outcomes in the patients with nasal cavity and paranasal sinus
malignancies. J Radiat Res. 2012 Sep. 53(5):704-9

SmithS.R.,SomP.,FahmyA.,LawsonW.,SacksS.,BrandweinM.AClinicopathological
Study of Sinonasal Neuroendocrine Carcinoma and Sinonasal Undifferentiated
Carcinoma.TheLaryngoscope.,2000Oct;110(10):16171622.
Cohen Z.R., Marmor E., Fuller G.N., Demonte F. Misdiagnosis of olfac tory
neuroblastoma.
NeurosurgFocus.,2002;12:e3.